Literature DB >> 30374842

Magnetic resonance imaging features of gelatinous pseudocysts in cryptococcal meningoencephalitis.

Ping Zhang1, Lifei Lian1, Furong Wang2.   

Abstract

Entities:  

Keywords:  Cryptococcal meningoencephalitis; Gelatinous pseudocysts; Magnetic resonance imaging

Mesh:

Year:  2018        PMID: 30374842      PMCID: PMC6534519          DOI: 10.1007/s13760-018-1033-6

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


× No keyword cloud information.

Introduction

Cryptococcosis is the most common mycotic infection of the central nervous system (CNS). It more frequently occurs as an opportunistic infection in patients with either human immunodeficiency virus (HIV) infection or other immunocompromised conditions. CNS cryptococcosis primarily manifests as meningitis [1]. The pseudocysts and the granulomas of the choroid plexuses were reported to be specific findings on magnetic resonance imaging (MRI) [2]. We describe here a HIV seronegative case of cryptococcal meningoencephalitis presenting multiple gelatinous pseudocysts.

Case report

A 35-year-old woman with a history of autoimmune hemolytic anemia and longtime prednisone taken presented with headache, fever and altered mental status. Neurological examination revealed meningeal irritation and bilateral pathological reflex of Babinski sign. Brain MRI showed bilateral and multiple hypointense T1 (not shown) and hyperintense T2 soap bubble-like gelatinous pseudocysts at the periventricular white matter, basal ganglia, midbrain and dentate nucleus, with mild post-gadolinium enhancement at bilateral basal ganglia (Fig. 1 a–e). Lumbar puncture was performed with cerebral spinal fluid (CSF) pressure of 350 mmH2O. CSF was clear with a protein level of 359 mg/L (normal range: 150–450 mg/L), a glucose level of 0.54 mmol/L (normal range 2.22–3.89 mmol/L), but without leukocytes. India ink staining of CSF found Cryptococcus neoformans (Fig. 1f) and fungal spores. Fungal culture and cryptococcal capsular polysaccharide antigen test of CSF confirmed CNS cryptococcal infection. Subsequently, blood culture also revealed cryptococcal infection. Serum HIV test of this patient was negative. However, lymphocyte count in the peripheral blood was as low as 0.03 × 109/L (normal range: 1.10–3.20 × 109/L). Peripheral blood lymphocyte subsets analysis revealed a significant reduction of all kinds of immune cells, especially the extremely reduced CD4 + T lymphocytes and NK cells (Table 1). Ultrasonography showed splenomegaly. Based on these findings, cryptococcal meningoencephalitis was diagnosed in this immunocompromised patient. Though received standard antifungal treatment, the patient died of cerebral hernia 3 weeks later.
Fig. 1

Imaging shows gelatinous pseudocysts in the brain of cryptococcal meningoencephalitis patient. T2-weighted magnetic resonance images show clusters of soap bubble-like gelatinous pseudocysts (arrows) at the periventricular white matter (a), basal ganglia (b, c), midbrain (c) and dentate nucleus (d). T1-post gadolinium shows mild enhancement at bilateral basal ganglia (e). India ink staining of CSF shows typical round encapsulated Cryptococcus neoformans (f)

Table 1

Peripheral blood lymphocyte subsets of the cryptococcal meningoencephalitis patient

ItemValueReference rangeUnit
Total T lymphocytes (CD3 + CD19-) (%)42.8450–84%
Total T lymphocytes (CD3 + CD19-) (#)34955–2860/µl
Total B lymphocytes (CD3-CD19+) (%)51.565–18%
Total B lymphocytes (CD3-CD19+) (#)4190–560/µl
Helper/induced T lymphocytes (CD3 + CD4+) (%)9.1127–51%
Helper/induced T lymphocytes (CD3 + CD4+) (#)7550–1440/µl
Suppressor/cytotoxic T lymphocytes (CD3 + CD8+) (%)29.3015–44%
Suppressor/cytotoxic T lymphocytes (CD3 + CD8+) (#)23320–1250/µl
NK cells (CD3-/CD16 + CD56+) (%)4.437–40%
NK cells (CD3-/CD16 + CD56+) (#)3150–1100/µl
T lymphocytes + B lymphocytes + NK cells (%)98.8395.00–105.00%
T lymphocytes + B lymphocytes + NK cells (#)78/µl
Th/Ts0.310.71–2.78
Imaging shows gelatinous pseudocysts in the brain of cryptococcal meningoencephalitis patient. T2-weighted magnetic resonance images show clusters of soap bubble-like gelatinous pseudocysts (arrows) at the periventricular white matter (a), basal ganglia (b, c), midbrain (c) and dentate nucleus (d). T1-post gadolinium shows mild enhancement at bilateral basal ganglia (e). India ink staining of CSF shows typical round encapsulated Cryptococcus neoformans (f) Peripheral blood lymphocyte subsets of the cryptococcal meningoencephalitis patient

Discussion

Cryptococcosis in most cases affects patients with acquired immune deficiency syndrome (AIDS). Less frequently, it can be found in other immunocompromised patients. In this case, the HIV seronegative patient had a history of autoimmune hemolytic anemia after she gave birth to her second baby. She took prednisone orally for 7 months and then stopped for 12 months before this onset. Anemia no longer existed. However, the extremely low peripheral blood lymphocyte count and the absence of leukocyte reactivity in CSF were clues of immunosuppression. Peripheral blood lymphocyte subsets analysis revealed a significant reduction of T lymphocytes and NK cells, which helped confirming immunodeficiency. Meningitis pronounced at the base of the brain is the primary pathological lesion of CNS cryptococcosis. Occasionally the meningeal infection can extend along perivascular spaces and give rise to small cysts in the Virchow–Robin spaces and adjacent brain, which term gelatinous pseudocysts [3]. Gelatinous pseudocysts exhibit soap bubble appearance by MRI, with a low to intermediate T1WI signal, a high T2WI signal and a low T2-FLAIR signal [4, 5]. In immunocompromised patients, the enhancements of the cystic lesions and meninges are usually mild or absent. These lesions can help the diagnosis of cryptococcal meningoencephalitis.
  5 in total

1.  Central nervous system cryptococcosis: parenchymal calcification and large gelatinous pseudocysts.

Authors:  K S Caldemeyer; V P Mathews; M K Edwards-Brown; R R Smith
Journal:  AJNR Am J Neuroradiol       Date:  1997-01       Impact factor: 3.825

2.  Magnetic resonance imaging findings in AIDS patients with central nervous system cryptococcosis.

Authors:  Marcelo Corti; Maria Florencia Villafañe; Ricardo Negroni; Alicia Arechavala; Elena Maiolo
Journal:  Rev Iberoam Micol       Date:  2008-12-31       Impact factor: 1.044

3.  CNS cryptococcosis in AIDS: spectrum of MR findings.

Authors:  C F Andreula; N Burdi; A Carella
Journal:  J Comput Assist Tomogr       Date:  1993 May-Jun       Impact factor: 1.826

4.  Soap bubble appearance in brain magnetic resonance imaging: cryptococcal meningoencephalitis.

Authors:  Marcelo Adriano da Cunha e Silva Vieira; Carlos Henrique Nery Costa; José Carlos Castelo Branco Ribeiro; Lucídio Portella Nunes-Filho; Marcos Glebson Gomes Rabelo; Walfrido Salmito de Almeida-Neto
Journal:  Rev Soc Bras Med Trop       Date:  2013 Sep-Oct       Impact factor: 1.581

Review 5.  The war on cryptococcosis: A Review of the antifungal arsenal.

Authors:  Ahmad Mourad; John R Perfect
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-19       Impact factor: 2.743

  5 in total
  3 in total

1.  Common and uncommon neuroimaging manifestations of ataxia: an illustrated guide for the trainee radiologist. Part 1 - acquired diseases.

Authors:  Vinicius de Menezes Jarry; Fernanda Veloso Pereira; Mariana Dalaqua; Juliana Ávila Duarte; Marcondes Cavalcanti França Junior; Fabiano Reis
Journal:  Radiol Bras       Date:  2022 Jul-Aug

Review 2.  MRI imaging features of HIV-related central nervous system diseases: diagnosis by pattern recognition in daily practice.

Authors:  Mio Sakai; Masahiro Higashi; Takuya Fujiwara; Tomoko Uehira; Takuma Shirasaka; Katsuyuki Nakanishi; Nobuo Kashiwagi; Hisashi Tanaka; Hitoshi Terada; Noriyuki Tomiyama
Journal:  Jpn J Radiol       Date:  2021-06-14       Impact factor: 2.374

3.  Gelatinous pseudocysts in cryptococcal meningoencephalitis.

Authors:  Bruno Niemeyer de Freitas Ribeiro; Edson Marchiori
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-13       Impact factor: 1.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.